The success of Viagra initially drove a surge for major pharmaceutical companies, but recent developments present a complicated scenario for shareholders. Off-patent versions are reducing profits, and persistent https://lanceqnqx116275.eedblog.com/41458029/viagra-and-big-pharma-a-risky-bet